| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 24.05.
| Today's Economic Outlook - Report Highlights Priceline.com Inc and Alexion Pharmaceuticals, Inc. | | 41 | MarketWire |
| HONG KONG -- (Marketwire) -- 05/24/12 -- Today, www.BrightonMarkets.com announced new reports highlighting Priceline.com Inc (NASDAQ: PCLN) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). Gain market...
Mehr lesen zu:
Today's Economic Outlook - Report Highlights Priceline.com Inc and Alexion Pharmaceuticals, Inc. | |
| 22.05.
| Shares of Alexion Pharmaceuticals Exhibit Possible Trend Reversal as it Trades Higher | | 13 | SmarTrend |
| 22.05.
| Stock Investors Bid Up Shares of Alexion Pharmaceuticals, Up 3.5% | | 5 | SmarTrend |
| 21.05.
| Alexion Pharma (ALXN) to Replace Motorola Mobility (MMI) in S&P 500 | | 12 | StreetInsider.com |
| 21.05.
| Alexion Pharmaceuticals Draws Call Buyers, Despite Recent Pullback | | 7 | Schaeffer's Research |
| 21.05.
| Alexion Pharmaceuticals - Wie geht es weiter? | | 37 | GodmodeTrader.de |
| 17.05.
| Alexion Downgraded to Neutral | | 7 | Zacks |
| 15.05.
| Bullish Moving Average Cross by Alexion Pharmaceuticals | | 3 | SmarTrend |
| 12.05.
| Alexion Pharmaceuticals Management Presents at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript) | | 6 | Seeking Alpha |
| 10.05.
| Alexion to Present at Bank of America Merrill Lynch 2012 Health Care Conference | | 47 | Business Wire |
| Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr.
Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will
present at the Bank of America...
Mehr lesen zu:
Alexion to Present at Bank of America Merrill Lynch 2012 Health Care Conference | |
| 10.05.
| Shares of Alexion Pharmaceuticals Rank the Highest in Terms of P/E Ratio in the Biotechnology Industry | | 5 | SmarTrend |
| 08.05.
| ALEXION - Kritischer Rückfall | | 32 | GodmodeTrader.de |
| 07.05.
| Vertex Is the Next Gilead Sciences or Alexion | | 25 | The Street |
| 02.05.
| Alexion Pharmaceuticals Shares Up 37.9% Since SmarTrend's Buy Recommendation | | 9 | SmarTrend |
| 30.04.
| Alexion to Present at Deutsche Bank Securities 37th Annual Health Care Conference | | 38 | Business Wire |
| Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas
Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present
at the Deutsche Bank Securities...
Mehr lesen zu:
Alexion to Present at Deutsche Bank Securities 37th Annual Health Care Conference | |
| 25.04.
| Alexion Pharmaceuticals Has Returned 34.8% Since SmarTrend Recommendation | | 5 | SmarTrend |
| 24.04.
| Alexion Pharmaceuticals Trending Down Despite Stellar Earnings | | 12 | Benzinga.com |
| 24.04.
| Alexion Q1 Profit Rises | | 67 | AFX News |
| WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals, Inc. (ALXN) posted
first-quarter net income of $45.4 million or $0.23 per share versus $26.8
million or $0.14 per share last year. Non-GAAP...
Mehr lesen zu:
Alexion Q1 Profit Rises | |
| 24.04.
| Alexion Reports First Quarter 2012 Results | | 44 | Business Wire |
| – Soliris® (eculizumab) Net Product Sales Increased 47
Percent OverYear-Ago Quarter to $244.7 Million –
– Continued Steady Growth in PNH –– aHUS Launch Progresses...
Mehr lesen zu:
Alexion Reports First Quarter 2012 Results | |
| 19.04.
| Zacks Bull and Bear of the Day Highlights: Alexion Pharmaceuticals, CSN, CBS, News Corporation and Comcast | | 35 | PR Newswire |
| CHICAGO, April 19, 2012 /PRNewswire/ --Zacks Equity Research highlights: Alexion Pharmaceuticals(Nasdaq: ALXN) as the Bull of the Day and CSN(NYSE: SID) as the Bear of the Day. In addition, Zacks...
Mehr lesen zu:
Zacks Bull and Bear of the Day Highlights: Alexion Pharmaceuticals, CSN, CBS, News Corporation and Comcast | |
